Propranolol delays the formation of aneurysms in the male blotchy mouse
- PMID: 3379945
- DOI: 10.1016/0022-4804(88)90101-1
Propranolol delays the formation of aneurysms in the male blotchy mouse
Abstract
Propranolol has been reported to prevent aortic aneurysms in the beta-aminoproprionitrile-fed broad-breasted white turkey model. The purpose of this investigation was to determine the effect of propranolol in another animal model of aortic aneurysms, the spontaneously aneurysm-prone Blotchy (BLO) mouse. One hundred fourteen male BLO mice were fed control chow or a diet supplemented with 0.10% (w/w) propranolol. Groups were sacrificed at monthly intervals and the presence of aneurysms was determined after latex injection into the left ventricle. Aortic diameter was also measured at the widest point in a subset of mice from each group sacrificed at 4-5 months of age. At 4 months 86% of control and 32% of propranolol-fed animals had aneurysms (P less than 0.001). The difference in mean aortic diameter was also decreased by 33% in the propranolol-fed group (P less than 0.01). This study suggests that propranolol delays the formation of aneurysms in this spontaneous, genetically determined animal model.
Similar articles
-
Inhibition of aortic aneurysm development in blotchy mice by beta adrenergic blockade independent of altered lysyl oxidase activity.J Vasc Surg. 1995 May;21(5):792-9; discussion 799-800. doi: 10.1016/s0741-5214(05)80010-2. J Vasc Surg. 1995. PMID: 7769737
-
Propranolol stimulates the crosslinking of matrix components in skin from the aneurysm-prone blotchy mouse.J Surg Res. 1989 Apr;46(4):330-2. doi: 10.1016/0022-4804(89)90197-2. J Surg Res. 1989. PMID: 2704229
-
The B-aminopropionitrile-fed turkey: a model for detecting potential drug action on arterial tissue.Cardiovasc Res. 1983 Jan;17(1):26-32. doi: 10.1093/cvr/17.1.26. Cardiovasc Res. 1983. PMID: 6850714
-
Relevance of angiotensin II-induced aortic pathologies in mice to human aortic aneurysms.Ann N Y Acad Sci. 2011 Dec;1245:7-10. doi: 10.1111/j.1749-6632.2011.06332.x. Ann N Y Acad Sci. 2011. PMID: 22211965 Review.
-
Pathogenesis of acquired aneurysms of the abdominal aorta.Ann Vasc Surg. 1992 May;6(3):298-305. doi: 10.1007/BF02000279. Ann Vasc Surg. 1992. PMID: 1610664 Review.
Cited by
-
Beta-Blockers and Abdominal Aortic Aneurysm Growth: A Systematic Review and Meta-Analysis.Curr Cardiol Rev. 2021;17(4):e230421187502. doi: 10.2174/1573403X16999201102213619. Curr Cardiol Rev. 2021. PMID: 33143615 Free PMC article.
-
Pharmacotherapy in Clinical Trials for Abdominal Aortic Aneurysms: A Systematic Review and Meta-Analysis.Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221120423. doi: 10.1177/10760296221120423. Clin Appl Thromb Hemost. 2022. PMID: 36083182 Free PMC article.
-
Lessons from Animal Models of Arterial Aneurysm.Aorta (Stamford). 2013 Oct 1;1(5):244-54. doi: 10.12945/j.aorta.2013.13-052. eCollection 2013 Oct. Aorta (Stamford). 2013. PMID: 26798701 Free PMC article. Review.
-
Etiology and pathogenesis of the Marfan syndrome: current understanding.Ann Cardiothorac Surg. 2017 Nov;6(6):595-598. doi: 10.21037/acs.2017.10.04. Ann Cardiothorac Surg. 2017. PMID: 29270371 Free PMC article. Review.
-
Current Status and Perspectives on Pharmacologic Therapy for Abdominal Aortic Aneurysm.Curr Drug Targets. 2018;19(11):1265-1275. doi: 10.2174/1389450119666171227223331. Curr Drug Targets. 2018. PMID: 29284386 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical